A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2004
12/29/2004	CA2529154A1 Novel compounds that modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	CA2528603A1 Thienopyridone derivatives as kinase inhibitors
12/29/2004	CA2528317A1 Hydroxamate sulfonamides as cd23 shedding inhibitors
12/29/2004	CA2528316A1 Hydroxamate sulfonamides as cd23 shedding inhibitors
12/29/2004	CA2527085A1 Synthetic peptide combinations and methods for the production thereof
12/29/2004	CA2524700A1 N-substituted 6,8-dialkoxy-1,2,3,4-tetrahydro-1h-isoquinoline as potassium channels modulators
12/28/2004	US6835837 Antiallergens; antiinflammatory agents; skin disorders; osteoporosis
12/28/2004	US6835818 Mutants of Streptococcal toxin C and methods of use
12/28/2004	US6835753 Administering to the patient for inhibiting Fc receptor binding of immunoglobulin a compound selected from aromatic, heteroaromatic, cyclic, bicyclic and an amino acid derivative or salt
12/28/2004	US6835752 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient
12/28/2004	US6835749 Sulfohydroxamic acids and sulfohydroxamates and their use as MEK inhibitors
12/28/2004	US6835738 Phenylalanine enamide derivatives
12/28/2004	US6835737 Quinoline inhibitors of cGMP phosphodiesterase
12/28/2004	US6835731 Chemokine receptor binding heterocyclic compounds
12/28/2004	US6835711 Use of poly-Glu,Tyr for neuroprotective therapy
12/28/2004	US6835550 Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
12/28/2004	US6835546 Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
12/28/2004	US6835372 Mixtures of di-(tri)peptides and drugs such as cyclosporin used as aerosols; drug delivery
12/28/2004	CA2226039C Pyridylfuran and pyridylthiophene compounds
12/28/2004	CA2126072C Tri-substituted phenyl derivatives and processes for their preparation
12/23/2004	WO2004111226A1 Urokinase plasminogen activator derived octapeptide in the treatment of multiple sclerosis
12/23/2004	WO2004111086A2 Peptide analogues comprising at least one type of aminoacyl aza-$g(b)3 and the use thereof, in particular for therapy
12/23/2004	WO2004111071A1 5'-aminocarbonyl-phosphonates d4t inhibitors for reproducing human immunodeficiency virus
12/23/2004	WO2004111054A1 Pyridinylpyrazolopyrimidinone derivatives as pde 7 inhibitors
12/23/2004	WO2004111053A1 Imidazotriazinone derivatives as pde 7 (phosphodiesterase 7) inhibitors
12/23/2004	WO2004111038A1 5,6-bis (4-chlorophenyl)-n-piperidin1-yl-3-(piperidin-1-yl-carbonyl)pyrazine-2-carboxamide
12/23/2004	WO2004111037A1 Cyclic tertiary amine compound
12/23/2004	WO2004111033A1 2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
12/23/2004	WO2004110980A1 Sphingolipids' polyalkylamines conjugates
12/23/2004	WO2004110979A2 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
12/23/2004	WO2004110499A1 Sphingolipids polyalkylamine conjugates for use in transfection
12/23/2004	WO2004110496A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	WO2004110489A1 MEDICINAL COMPOSITION FOR PREVENTING OR TREATING Th1 TYPE IMMUNOLOGICAL DISEASE
12/23/2004	WO2004110454A1 COMPOSITION FOR TREATMENT FOR OR PREVENTION OF DISEASE NECESSITATING ADMINISTRATION OF ADENOSINE A2a RECEPTOR AGONIST
12/23/2004	WO2004110390A2 Anti-cd74 immunoconjugates and methods
12/23/2004	WO2004110379A2 A1 adenosine receptor antagonists
12/23/2004	WO2004087203A3 Immunostimulatory nucleic acid oil-in-water formulations for topical application
12/23/2004	WO2004045563A3 Method of treatment of myocardial infarction
12/23/2004	WO2003106692A3 Methods for the identification of all-antigens and their use for cancer therapy and transplantation
12/23/2004	US20040259952 Formulations for oral administration of cromolyn sodium
12/23/2004	US20040259936 Patients in need of anticancer treatment or treatment of lymphomas or autoimmune disease
12/23/2004	US20040259935 Novel antiallergens ond prevention of allergenic diseases using polylactic acid to combat rhinitis
12/23/2004	US20040259930 Linear basic compounds having nk-2 antagonist activity and formulations thereof
12/23/2004	US20040259928 Enzyme inhibitors for antidiabetic agents, antitumor disorders, treatment of skin disorters, anticancer agents and cognitive activators for Alzheimers disease treatment
12/23/2004	US20040259897 transplant rejection, rheumatoid arthritis, osteoarthritis, diabetes, asthma, inflammatory bowel disease, and chronic obstructive pulmonary disease; inhibitors of Lymphocyte Function-associated Antigen 1 (LFA-1)/intercellular adhesion molecule (ICAM); 2,4-dioxo-1,3,7-triazaspiro[4.4]nonanes
12/23/2004	US20040259893 Use of tyrosine kinase inhibitions for treating allergic diseases
12/23/2004	US20040259876 Bicyclic compound, production and use thereof
12/23/2004	US20040259863 Type 4 phosphodiesterase inhibitors and uses thereof
12/23/2004	US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease
12/23/2004	US20040259838 Staphylococcus aureus exopolysaccharide and process
12/23/2004	US20040259826 Mitotic kinesin inhibitors
12/23/2004	US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents
12/23/2004	US20040259820 Kit for delivering decitabine in vivo
12/23/2004	US20040259787 C1q and collectin receptor
12/23/2004	US20040259781 Drug screening ; polypeptide interfers with binding of fibronectin to; anticancer agents; antihistamines, antiarthritic agents, autoimmune disease, wound healing agents
12/23/2004	US20040259248 RNA interference mediating small RNA molecules
12/23/2004	US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference)
12/23/2004	US20040259201 Recombinant surfactant protein D compositions and methods of use thereof
12/23/2004	US20040259150 Method of enhancing of binding activity of antibody composition to Fcgamma receptor IIIa
12/23/2004	US20040259103 NKR (Natural Killer Receptor); rapidly analyze physiological and pathological situations linked to these repertoires; use in diagnosise/prognosis of patients for transplant acceptance, resistance to infections and disease, and in drug screening for autoimmune diseases, antitumor agents, and antibiotics
12/23/2004	US20040258772 Methods of treating angiogenesis, tumor growth, and metastasis
12/23/2004	US20040258717 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of the healthy-skin
12/23/2004	US20040258704 Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation
12/23/2004	US20040258678 Isolated nucleic acid having high identity to sequence 215; vectors, host cells, antibodies
12/23/2004	US20040258672 Graft acceptance through manipulation of thymic regeneration
12/23/2004	US20040258656 Identified via SELEX method; phosphate-containing ligand is conjugated to polyoxyethylene glycol; transforming growth factor (TGF); pharmacokinetics
12/23/2004	DE10325049A1 New peptide derivatives containing cell-adhesion molecule and phosphonate-containing anchor component, useful for treating disorders associated with implants, are inhibitors of integrins
12/23/2004	CA2529496A1 Anti-cd74 immunoconjugates and methods
12/23/2004	CA2528929A1 Cyclic tertiary amine compound
12/23/2004	CA2528883A1 Pharmaceutical compositions for preventing or treating th1-mediated immune diseases
12/23/2004	CA2528402A1 Sphingoid polyalkylamine conjugates for vaccination
12/23/2004	CA2528367A1 A1 adenosine receptor antagonists
12/23/2004	CA2527977A1 Amino-propanol derivatives as sphingosine-1-phosphate receptor modulator
12/23/2004	CA2527033A1 2-substitued 5,6-diaryl-pyrazine derivatives as cb1 modulators
12/23/2004	CA2525966A1 Novel immunomodulating peptide
12/22/2004	EP1489185A1 Methods and compositions for use in splicesome mediated rna trans-splicing
12/22/2004	EP1489183A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
12/22/2004	EP1489172A1 Nuclear receptor err gamma 3
12/22/2004	EP1489100A2 Heterodimeric fusion proteins useful for targeted immune therapy and general immune stimulation
12/22/2004	EP1489099A2 Antibodies that bind the CD40CR receptor
12/22/2004	EP1489088A1 Novel alpha-amino-n-(diaminophosphinyl)lactam derivative
12/22/2004	EP1489081A1 Spiro derivatives and adhesion molecule inhibitors comprising the same as the active ingredient
12/22/2004	EP1489071A1 N-substituted, 3,4-dihydro-1H-isoquinoline as potassium channels modulators
12/22/2004	EP1488805A2 CD28 pathway immunoregulation
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488792A2 Quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
12/22/2004	EP1487998A2 Methods for diagnosing and treating schizophrenia
12/22/2004	EP1487971A2 MEANS AND METHODS FOR MANIPULATING HYPERSENSITIVITY−LIKE RESPONSES
12/22/2004	EP1487970A2 Tolerogenic antigen-presenting cells
12/22/2004	EP1487879A2 Bispecific antibody point mutations for enhancing rate of clearance
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487869A1 Novel allergen
12/22/2004	EP1487865A2 USES OF MAMMALIAN CYTOKINEi; RELATED REAGENTS
12/22/2004	EP1487842A1 An optically acitve pyridine derivative and a medicament containing the same
12/22/2004	EP1487841A1 Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
12/22/2004	EP1487827A1 Anti-inflammatory morpholin-acetamide derivatives
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487821A1 Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases
12/22/2004	EP1487817A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487811A1 N-sulfonylurea apoptosis promoters

1 ... 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 ... 1172